Interleukin-7: Fuel for the autoimmune attack

H Dooms - Journal of autoimmunity, 2013 - Elsevier
H Dooms
Journal of autoimmunity, 2013Elsevier
Abstract Interleukin-7 (IL-7) is a critical survival factor for lymphocytes and recent studies
suggest targeting the IL-7/IL-7Rα pathway holds promise for the treatment of autoimmune
diseases. Several lines of evidence, genetic as well as functional, indicate an important role
for this cytokine in autoimmune inflammation: polymorphisms in the IL-7Rα have been
associated with increased risk for autoimmune disease and blocking IL-7/IL-7Rα with
antibodies showed therapeutic efficacy in several autoimmune mouse models. Insights are …
Abstract
Interleukin-7 (IL-7) is a critical survival factor for lymphocytes and recent studies suggest targeting the IL-7/IL-7Rα pathway holds promise for the treatment of autoimmune diseases. Several lines of evidence, genetic as well as functional, indicate an important role for this cytokine in autoimmune inflammation: polymorphisms in the IL-7Rα have been associated with increased risk for autoimmune disease and blocking IL-7/IL-7Rα with antibodies showed therapeutic efficacy in several autoimmune mouse models. Insights are starting to emerge about the mechanisms underlying IL-7's role in autoimmunity and tolerance, revealing surprising novel functions beyond its traditional activity as a T cell survival factor. In the first part of this review, the functions of IL-7 in the immune system are concisely described, providing a basis for understanding their potential role in promoting autoimmune responses. In the second part, current knowledge about the role of IL-7 in various autoimmune conditions is reviewed.
Elsevier